Target intelligence / Profile preview

Glycosylated lysosomal membrane protein (GLMP)

Target
GLMP
Molecular classification
Single-pass transmembrane protein, Lysosomal membrane protein, Transporter accessory subunit, Glycoprotein
01

Overview

Glycosylated lysosomal membrane protein (GLMP) is a highly glycosylated, single-pass transmembrane protein found on the lysosomal membrane where it serves as an essential accessory subunit for the lysosomal dipeptide transporter MFSD1. GLMP protects MFSD1 from lysosomal proteolysis and is required for its proper localization to the lysosome. The MFSD1-GLMP complex functions as a general uniporter for cationic, neutral, and anionic dipeptides, establishing an alternative export pathway for proteolysis products in lysosomes. Deficiency of GLMP (or MFSD1) leads to severe organ dysfunction, highlighting its importance in cellular degradation and metabolite recycling. Although closely related to other lysosomal membrane proteins (such as LAMP family proteins), GLMP is a distinct protein and critical for lysosomal transporter function.

Other names
C1orf85PSEC0030UNQ2553/PRO6182MGC31963NCU-G1Lysosomal protein NCU-G1Kidney lysosomal membrane proteinGlycosylated lysosomal membrane proteinlnc-UCID
02

Mechanism of action

No drugs targeting GLMP explicitly; mechanisms for potential targeting would likely involve modulation of MFSD1-GLMP transporter function or lysosomal stability.

03

Biological functions

Protects lysosomal transporter MFSD1 from lysosomal proteolysisRequired for proper lysosomal localization of MFSD1Accessory subunit in the MFSD1-GLMP dipeptide uniporter, facilitating dipeptide transport across the lysosomal membraneMay participate in transcription regulation (some annotations reference positive regulation of transcription by RNA polymerase II, though this may pertain to locus-level complexity)
04

Disease associations

Lysosomal storage disorders (functional deficiency in mouse models leads to phenotypes reminiscent of lysosomal transporter defects, including liver disease and splenomegaly)Cancer (associations with hepatocellular carcinoma and Noonan Syndrome 8)Potential relevance to kidney function (alias includes "kidney lysosomal membrane protein")
05

Safety considerations

No direct safety data; functional deficiency leads to organ dysfunction in model organisms, which could inform caution for future therapeutic targeting.

Beyond the preview

Go deeper on Glycosylated lysosomal membrane protein (GLMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosylated lysosomal membrane protein (GLMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call